Mangalam Drugs VS Pharmaceuticals & Biotechnology 
1D
-0.07%
-0.49%
1W
-1.39%
-0.35%
1M
-3.61%
0.75%
YTD
-2.17%
-8.29%
1Y
-65.05%
-3.04%
3Y
-74.66%
19.64%
5Y
-81.19%
43.33%
10Y
-83.83%
180.53%
- Stock Absolute Returns
- India SENSEXAbsolute Returns
Price + DividendTotal Returns (Price + Dividend) 
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-12.74%
0%
-12.74%
6 Months
-21.72%
0%
-21.72%
1 Year
-65.05%
0%
-65.05%
2 Years
-77.07%
0%
-77.07%
3 Years
-74.66%
0%
-74.66%
4 Years
-81.43%
0%
-81.43%
5 Years
-81.19%
0%
-81.19%
Latest dividend: 0.5 per share ex-dividend date: Dec-21-2017
Return QuartilesWhat is a Quartile?
Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.
Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on
Return Quartiles - by Closest Peers
Inconsistent Performance
Mangalam Drugs and Organics Ltd has not been a consistent performer in the YTD and longer periods
2
Quartile
QTD
-5.36%
4
Quartile
Mar-Jun
2.81%
1
Quartile
Dec-Mar
0.54%
4
Quartile
YTD
-65.44%
4
Quartile
2025
-76.21%
1
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry
Underperformer
Mangalam Drugs and Organics Ltd has been in the Third and Fourth Quartile in the YTD and longer periods
3
Quartile
QTD
-5.36%
4
Quartile
Mar-Jun
2.81%
1
Quartile
Dec-Mar
0.54%
4
Quartile
YTD
-65.44%
4
Quartile
2025
-76.21%
3
Quartile
2024
18.09%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap
Not enough Stock Price history for Quartile Analysis
Risk Adjusted Returns v/s India SENSEXRisk Adjusted Returns v/s
Returns BetaReturns Beta
Beta has not been calculated since enough price history is not available
